Source National Multiple Sclerosis Society: Researchers from the Harvard T.H. Chan School of Public Health in Boston and collaborators report on a study that examined blood (serum) samples from 60 military personnel who went on to develop multiple sclerosis years later. Compared to samples from a control group, those who eventually developed MS showed higher than […]
New Study Asks: When Does MS Begin? Read More »
Source Multiple Sclerosis News Today: Recovering well after a first relapse and starting a disease-modifying therapy (DMT) immediately afterwards considerably increases the likelihood of slowing progression in multiple sclerosis (MS), a study suggests. Its findings support relapse recovery as a critical factor for DMT initiation, and one that should be assessed routinely in MS clinical trials, researchers said. The
MS Progression Affected by Degree of Relapse Recovery and Timing of DMT Use, Study Says Read More »
Source The Guardian: The barrier between mind and body appears to be crumbling. Clinical practice and public perception need to catch up. Unlikely as it may seem, #inflammation has become a hashtag. It seems to be everywhere suddenly, up to all sorts of tricks. Rather than simply being on our side, fighting infections and healing wounds,
From depression to dementia, inflammation is medicine’s new frontier Read More »
Source Multiple Sclerosis News Today: Regeneration in the brain is reduced in people with primary progressive multiple sclerosis (PPMS), but enhanced during disease activity in those with relapsing-remitting MS (RRMS), a study reports.
Brain Regeneration Impaired in Progressive MS, Unaffected By DMTs, Study Reports Read More »
Source Multiple Sclerosis News Today: Regeneration in the brain is reduced in people with primary progressive multiple sclerosis (PPMS), but enhanced during disease activity in those with relapsing-remitting MS (RRMS), a study reports.
Source MS Society: Virtual reality, wearable robots and magnetic brain stimulation. Technology is at the forefront of 13 new research projects we’ve just announced.
The MS Society is excited to announce their 13 new MS research projects Read More »
Source Medical Xpress: Watching immersive 360 videos of icy Arctic scenes helps to relieve intense burning pain and could hold hope for treating chronic pain, a small study has found.
Immersion in virtual reality scenes of the Arctic helps to ease people’s pain Read More »
Source MS Trust: Sativex is a cost-effective treatment for people with MS spasticity according to new guidance published today by NICE(link is external). This reverses the decision made in draft guidance published earlier this year.
Sativex cost-effective in final NICE guideline on cannabis-based medicines Read More »
Source MS Trust: Lemtrada (alemtuzumab) should be restricted to people with highly active relapsing-remitting MS according to a review carried out by the European Medicines Agency’s (EMA) drug safety committee.
European drug regulator recommends restricted use of Lemtrada Read More »
Source BBC: Two cannabis-based medicines, used to treat epilepsy and multiple sclerosis, have been approved for use by the NHS in England.
Cannabis-based medicines: Two drugs approved for NHS Read More »
